TY  - GEN
AU  - Perez de Isla,Leopoldo
AU  - Alonso,Rodrigo
AU  - Watts,Gerald F
AU  - Mata,Nelva
AU  - Saltijeral Cerezo,Adriana
AU  - Muñiz,Ovidio
AU  - Fuentes,Francisco
AU  - Diaz-Diaz,José Luís
AU  - de Andrés,Raimundo
AU  - Zambón,Daniel
AU  - Rubio-Marin,Patricia
AU  - Barba-Romero,Miguel A
AU  - Saenz,Pedro
AU  - Sanchez Muñoz-Torrero,Juan F
AU  - Martinez-Faedo,Ceferino
AU  - Miramontes-Gonzalez,José P
AU  - Badimón,Lina
AU  - Mata,Pedro
TI  - Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia: 5-Year SAFEHEART Registry Follow-Up
SN  - 1558-3597
PY  - 2016///0802
KW  - Adolescent
KW  - Adult
KW  - Anticholesteremic Agents
KW  - therapeutic use
KW  - Atorvastatin
KW  - administration & dosage
KW  - Biomarkers
KW  - blood
KW  - Cholesterol, LDL
KW  - Dose-Response Relationship, Drug
KW  - Drug Therapy, Combination
KW  - Ezetimibe
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Hydroxymethylglutaryl-CoA Reductase Inhibitors
KW  - Hyperlipoproteinemia Type II
KW  - Male
KW  - Middle Aged
KW  - Prospective Studies
KW  - Registries
KW  - Rosuvastatin Calcium
KW  - Spain
KW  - epidemiology
KW  - Time Factors
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.jacc.2016.01.008
ER  -